DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Charles P, Terrier B, Perrodeau É. et al.
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
Ann Rheum Dis 2018;
77: 1143-1149
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.